TrialBMC cancer2022

A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO).

Charbel Elias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.